| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in operating activities | -2,043,969 | -1,385,722 |
| Net change in cash | -2,043,969 | -1,385,722 |
| Cash and cash equivalents at beginning of period | 6,165,568 | - |
| Cash and cash equivalents at end of period | 4,121,599 | - |
Xenetic Biosciences, Inc. (XBIO)
Xenetic Biosciences, Inc. (XBIO)